biblio

Export 17 results:
Filters: First Letter Of Title is D and Author is Sarkar, Dhiman  [Clear All Filters]
2005
U. Singh, Panchanadikar, V., and Sarkar, D., “Development of a simple assay protocol for high-throughput screening of mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 10, no. 7, pp. 725-729, 2005.
2006
U. Singh and Sarkar, D., “Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 11, no. 8, pp. 1035-1042, 2006.
2015
V. S. Pore, Divse, J. M., Charolkar, C. R., Nawale, L. U., Khedkar, V. M., and Sarkar, D., “Design and synthesis of 11 alpha-substituted bile acid derivatives as potential anti-tuberculosis agents”, Bioorganic & Medicinal Chemistry Letters, vol. 25, no. 19, pp. 4185-4190, 2015.
A. C. Lele, Raju, A., Khambete, M. P., Ray, M. K., Rajan, M. G. R., Arkile, M. A., Jadhav, N. J., Sarkar, D., and Degani, M. S., “Design and synthesis of a focused library of diamino triazines as potential mycobacterium tuberculosis DHFR inhibitors”, ACS Medicinal Chemistry Letters, vol. 6, no. 11, pp. 1140-1144, 2015.
L. Nawale and Sarkar, D., “Discovery of new chemical entities against diseases of national importance :an HTS approach”, in National Science Day, At CSIR-NCL, Combi Chem-Bio Resource Center, OCD, National Chemical Laboratory, Pune - 411 008, 2015.
2016
P. K. Gadekar, Roychowdhury, A., Kharkar, P. S., Khedkar, V. M., Arkile, M. A., Manek, H., Sarkar, D., Sharma, R., Vijayakumar, V., and Sarveswari, S., “Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents”, European Journal of Medicinal Chemistry, vol. 122, pp. 475-487, 2016.
2018
M. A. Wagh, Baravkar, S. B., Jedhe, G. S., Borkute, R., Choudhari, A. S., Sarkar, D., and Sanjayan, G. J., “Design and synthesis of 2-amino-thiophene-tethered ureidopenicillin analogs with potentantibacterial and antitubercular activity”, ChemistrySelect, vol. 3, no. 11, pp. 3122-3126, 2018.
M. S. Tambe, Choudhari, A., Sarkar, D., Sangshetti, J., Patil, R., and Gholap, S. S., “Design, synthesis and biological screening of novel 1,3,4-oxadiazoles as antitubercular agents”, Chemistryselect, vol. 3, no. 47, pp. 13304-13310, 2018.
S. Gholap, Tambe, M., Nawale, L., Sarkar, D., Sangshetti, J., and Damale, M., “Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents”, Archiv Der Pharmazie, vol. 351, no. 2, p. e1700294, 2018.
R. Gawali, Trivedi, J., Bhansali, S., Bhosale, R., Sarkar, D., and Mitra, D., “Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted-2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors”, European Journal of Medicinal Chemistry, vol. 157, pp. 310-319, 2018.
2019
S. B. Baravkar, Wagh, M. A., Nawale, L. U., Choudhari, A. S., Bhansali, S., Sarkar, D., and Sanjayan, G. J., “Design and synthesis of 2-amino-thiophene-proline-conjugates and their anti-tubercular activity against mycobacterium tuberculosis H37Ra”, ChemistrySelect, vol. 4, no. 9, pp. 2851-2857, 2019.
A. Atmaram Upare, Gadekar, P. K., Sivaramakrishnan, H., Naik, N., Khedkar, V. M., Sarkar, D., Choudhari, A., and S. Roopan, M., “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
2022
D. D. Subhedar, Shaikh, M. H., Nagargoje, A. A., Sarkar, D., Khedkar, V. M., and Shingate, B. B., “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.
S. Sarkar, Swami, S., Soni, S. Kumar, Holien, J. K., Khan, A., Korwar, A. M., Likhite, A. P., Joshi, R. A., Joshi, R. R., and Sarkar, D., “Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols”, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.
G. Navale, Singh, S., Agrawal, S., Ghosh, C., Choudhury, A. Roy, Roy, P., Sarkar, D., and Ghosh, K., “DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium(ii) complexes”, Dalton Transactions, vol. 51, no. 42, pp. 16371-16382, 2022.
2023
S. Singh, Navale, G. R., Agrawal, S., Singh, H. Kisan, Singla, L., Sarkar, D., Sarma, M., Choudhury, A. Roy, and Ghosh, K., “Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid ? (1-42) peptide aggregation”, International Journal of Biological Macromolecules, vol. 239, p. 124197, 2023.
R. Mamgain, Swami, S., Sarkar, D., and Srivastava, P., “Design, synthesis, and in vitro biological evaluation of ROS-generating phenanthridin-trione-epoxide conjugates as agents against mycobacterium tuberculosis”, ChemistrySelect, vol. 8, no. 25, p. e202300416, 2023.